Small Cell Lung Carcinoma Sclc Clinical Trials

3 clinical trials found for Small Cell Lung Carcinoma Sclc.

Pipeline by Phase

PhaseTrialsDistribution
Phase 1 3
100%

Trial Status Breakdown

Trials for Small Cell Lung Carcinoma Sclc

DAREONᵀᴹ-8: A Phase I, Open-label, Dose Escalation and Expansion Trial of Repeated Intravenous Infusions of BI 764532 Combined With Standard of Care (Platinium, Etoposide, and Anti-PD-L1) in Patients With Extensive-stage Small Cell Lung Carcinoma

NCT06077500 · ACTIVE NOT RECRUITING · Phase 1

DAREON™-9: A Phase Ib Open-label Dose Escalation and Dose Confirmation Safety Study of Intravenous BI 764532 in Combination With a Single Agent Chemotherapy for the Treatment of Patients With Relapsed/Refractory Small Cell Lung Cancer After Platinum-based Chemotherapy

NCT05990738 · ACTIVE NOT RECRUITING · Phase 1

A Phase I, Non-randomized, Open-label, Multi-center Dose Escalation Trial of Obrixtamig (BI 764532) Combined With Ezabenlimab in Patients With Small Cell Lung Carcinoma and Other Neuroendocrine Neoplasms Expressing DLL3

NCT05879978 · ACTIVE NOT RECRUITING · Phase 1

Frequently Asked Questions

What clinical trials are available for Small Cell Lung Carcinoma Sclc?

There are 3 clinical trials listed for Small Cell Lung Carcinoma Sclc. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Small Cell Lung Carcinoma Sclc trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Small Cell Lung Carcinoma Sclc trials in?

Current Small Cell Lung Carcinoma Sclc trials are distributed across: Phase 1 (3).

Find More Trials